Steven Salzberg wrote earlier this week about GlaxoSmithKline’s marketing of fish oil, a supplement, as a drug in the form of its omega-3 fatty acid pill, Lovaza. I took issue with his post, because I think the data for the fish oil omega-3s, DHA and EPA, are pretty strong. (I’ve previously written about this here [...]
does anyone know the real story